Welcome to LookChem.com Sign In|Join Free

CAS

  • or

25445-34-5

Post Buying Request

25445-34-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

25445-34-5 Usage

Molecular weight

209.08 g/mol
The molecular weight of the compound is 209.08 grams per mole, which is the mass of one mole of the compound.

Physical state

Colorless liquid
2,4-bis(chloromethyl)-1-methoxybenzene is a colorless liquid, meaning it does not have any color when in its liquid state.

Odor

Strong, pungent
The compound has a strong and pungent odor, which can be irritating or overpowering.

Primary use

Intermediate in the production of pharmaceuticals, dyes, and other organic compounds
The main application of 2,4-bis(chloromethyl)-1-methoxybenzene is as a chemical intermediate, which is a substance used in the synthesis of other compounds, such as pharmaceuticals, dyes, and other organic chemicals.

Synthesis of polymers

Yes
The compound is also used in the synthesis of polymers, which are large molecules made up of repeating subunits.

Chemical reagent

Used in various laboratory processes
2,4-bis(chloromethyl)-1-methoxybenzene serves as a chemical reagent in a variety of laboratory processes, such as chemical reactions and experiments.

Hazardous substance

Yes
The compound is considered hazardous, meaning it poses potential risks to human health and the environment.

Health risks

Skin and eye irritation, respiratory tract irritation, harmful effects if ingested or inhaled
Exposure to 2,4-bis(chloromethyl)-1-methoxybenzene can cause skin and eye irritation, respiratory tract irritation, and may have harmful effects if the substance is ingested or inhaled.

Safety measures

Proper safety measures and protective equipment should be used when handling
To minimize the risks associated with handling 2,4-bis(chloromethyl)-1-methoxybenzene, it is essential to follow proper safety procedures and use appropriate protective equipment, such as gloves, goggles, and lab coats.

Check Digit Verification of cas no

The CAS Registry Mumber 25445-34-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,4,4 and 5 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 25445-34:
(7*2)+(6*5)+(5*4)+(4*4)+(3*5)+(2*3)+(1*4)=105
105 % 10 = 5
So 25445-34-5 is a valid CAS Registry Number.

25445-34-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-methoxy-2,4-bis(chloromethyl)benzene

1.2 Other means of identification

Product number -
Other names Benzene, 2,4-bis(chloromethyl)-1-methoxy-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:25445-34-5 SDS

25445-34-5Relevant articles and documents

Synthesis and in vitro activities on anti-platelet aggregation of 4-methoxyisophthalamides

Liu, Xiujie,Wang, Yan,Liu, Lili,Chen, Guangling

, p. 1971 - 1983 (2018/07/02)

A series of 4-methoxyisophthalamides (1d–1w) were designed and synthesized and their chemical structures were confirmed by IR, MS, 1H-NMR, and 13C-NMR. The in vitro on anti-platelet aggregation activities of these compounds were assessed by using Born method. Compounds with higher activities were selected to continue research via Cell Counting Kit-8 (CCK-8) assays of their cytotoxicities. Biological screening results revealed four compounds 1h, 1i, 1q, and 1v exhibited higher activities than the control drugs on against the platelet aggregation induced by adenosine triphosphate (ADP). Moreover, compounds 1p and 1q exhibited higher in vitro activities than picotamide induced by collagen at the concentration of 1.3 μM. Compound 1p also possessed anti-platelet aggregation activity superior to the control drug picotamide induced by arachidonic acid (AA) at the concentration of 1.3 μM. At the same time, the result of cytotoxicities exhibited that none of the compounds have significant cytotoxicities. Therefore, 4-methoxyisophthalamides are potential to become novel anti-platelet drugs with high activities and minimum toxicities.

An experimental and theoretical study on imidazolium-based ionic liquid promoted chloromethylation of aromatic hydrocarbons

Wang, Yun,Xi, Yanli

, p. 2196 - 2199 (2014/03/21)

The chloromethylation of aromatic hydrocarbons proceeded efficiently using the reusable imidazolium-based ionic liquid as promoter. Mild reaction conditions, enhanced rates, improved yields, recyclability of ionic liquids, and reagents' reactivity which is different from that in conventional organic solvents are the remarkable features observed in ionic liquids. The ionic liquids were recycled in three subsequent runs with no decrease in activity. In addition, the results of calculations with the Gaussian 98 suite of program are in good accordance with the experimental outcomes.

Synthesis and in vitro activities on anti-platelet aggregation of N,N′-di(2-substituted-phenyl)-4-methoxy isophthalamides and benzene-1,3-disulfonamides

Liu, Xiu Jie,He, Xin,Shi, Cheng Ling,Meng, Jie,Shao, Ying Lu,Si, Hong Qiang,Hu, Tao

scheme or table, p. 1139 - 1142 (2012/01/06)

On the propose of searching for the SAR and obtaining novel antiplatelet aggregating drugs, we have described the synthesis procedure and the activities in vitro on antiplatelet aggregation of two series of derivatives, which contain both 18 N,N′-di(2-substitutedphenyl)-4-methoxyisophthalamides (2a-2r) of the 2 series and nine N,N′-di(2-substitutedphenyl)-4-methoxybenzene-1,3- disulfonamides (3a-3i) of the 3 series. The results showed that three compounds 2e, 2i and 3g emerged as significant activities of antiplatelet aggregation, superior to two reference drugs picotamide and aspirin, and eight compounds 2j, 2k, 2l, 2o, 2p, 2q, 2r and 3i merely superior to picotamide. The preliminary SAR shows that it is favorable for the 2 series to increase the activities via the steric hindrance substituents attached to the two side chain benzene rings at 2-positions. And the arylamides of the 2 series have better the activity values than the arylsulfonamides of the 3 series respective except for 3b and 3g. On the contrary, electrostatic factors would not contribute evidently to the activities of the two series. The structures of 15 compounds newly synthesized have been established by MS and 1H NMR and been first reported in this paper.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 25445-34-5